Streptococcal infections encompass a diverse group of bacterial diseases affecting farm animals worldwide, caused by various species within the genus Streptococcus. These gram-positive bacteria are responsible for significant economic losses and welfare concerns across all major livestock species, manifesting as mastitis in dairy animals, respiratory disease and meningitis in swine, strangles in horses, and various other conditions. The streptococci are classified into different groups based on serological characteristics, with Lancefield groups A, B, C, D, and others having importance in veterinary medicine. Understanding the specific streptococcal species involved in infections is crucial for appropriate treatment selection, control measure implementation, and assessment of zoonotic risk, as certain species like Streptococcus suis pose significant public health concerns for farm workers and others with animal contact.
Streptococcal infections affect virtually every domesticated livestock species with varying disease presentations and economic impacts. In dairy cattle, streptococcal mastitis remains one of the most significant infectious diseases, with Streptococcus agalactiae causing highly contagious intramammary infections and environmental streptococci including Streptococcus uberis contributing substantially to clinical and subclinical mastitis cases. Swine operations face major challenges from Streptococcus suis, which causes meningitis, septicemia, arthritis, and pneumonia, particularly in weaned piglets, with significant mortality and treatment costs. Horses are affected by Streptococcus equi subspecies equi, causing strangles, a highly contagious upper respiratory infection with lymph node abscessation that can devastate equine populations. Sheep and goats experience streptococcal mastitis and various other manifestations of streptococcal disease.
The economic impact of streptococcal infections in farm animals is substantial and multifaceted, extending beyond direct treatment costs and mortality losses. Streptococcal mastitis in dairy operations causes decreased milk production, reduced milk quality with elevated somatic cell counts, treatment expenses, discarded milk during treatment and withdrawal periods, increased labor for managing affected animals, and premature culling of chronically infected cows. In swine production, Streptococcus suis causes mortality losses, reduced growth rates in survivors, treatment costs, and potential condemnation at slaughter. Strangles outbreaks in horse operations result in quarantine periods, treatment expenses, potential complications including bastard strangles and purpura hemorrhagica, and disruption of breeding, training, and competition schedules. The welfare implications include pain and suffering from acute infections, chronic discomfort from persistent conditions, and reduced quality of life for affected animals.
Early detection and appropriate treatment of streptococcal infections generally yield favorable outcomes, as many streptococcal species remain susceptible to commonly available antimicrobials. Unlike staphylococcal infections, streptococcal mastitis cases frequently achieve bacteriological cure with standard antimicrobial therapy, making prompt diagnosis and treatment particularly rewarding. However, certain conditions such as established strangles outbreaks, systemic Streptococcus suis infections, and chronic mastitis cases present greater treatment challenges. The emergence of antimicrobial resistance in some streptococcal populations underscores the importance of diagnostic testing and prudent antimicrobial use. Prevention programs incorporating biosecurity, vaccination where available, environmental management, and monitoring systems can significantly reduce streptococcal infection incidence and impact in well-managed operations. Collaboration between producers, veterinarians, and specialists enables development of effective control strategies tailored to specific farm situations and disease challenges.
